Analysts’ Weekly Ratings Changes for Merck KGaA (MRK)

Several analysts have recently updated their ratings and price targets for Merck KGaA (FRA: MRK):

2/18/2019 – Merck KGaA was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock. 2/12/2019 – Merck KGaA was given a new €95.00 ($110.47) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock. 2/12/2019 – Merck KGaA was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock. 2/12/2019 – Merck KGaA was given a new €108.00 ($125.58) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock. 2/11/2019 – Merck KGaA was given a new €90.00 ($104.65) price target on by analysts at Morgan Stanley. They now have a “neutral” rating on the stock. 2/11/2019 – Merck KGaA had its “neutral” rating reaffirmed by analysts at DZ Bank AG. 2/6/2019 – Merck KGaA was given a new €108.00 ($125.58) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock. 2/5/2019 – Merck KGaA was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock. 2/5/2019 – Merck KGaA was given a new €105.00 ($122.09) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock. 1/24/2019 – Merck KGaA was given a new €80.00 ($93.02) price target on by analysts at Nord/LB. They now have a “sell” rating on the stock. 1/24/2019 – Merck KGaA was given a new €108.00 ($125.58) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock. 1/15/2019 – Merck KGaA was given a new €78.00 ($90.70) price target on by analysts at Barclays PLC. They now have a “sell” rating on the stock. 1/15/2019 – Merck KGaA had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. 1/8/2019 – Merck KGaA was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock. 1/3/2019 – Merck KGaA was given a new €105.00 ($122.09) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock. 1/2/2019 – Merck KGaA was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.

Shares of Merck KGaA stock traded up €0.14 ($0.16) during trading hours on Monday, hitting €97.06 ($112.86). The company’s stock had a trading volume of 288,266 shares. Merck KGaA has a twelve month low of €76.60 ($89.07) and a twelve month high of €115.00 ($133.72).

MERCK Kommanditgesellschaft auf Aktien, a science and technology company, operates in the healthcare, life science, and performance materials sectors worldwide. The company offers prescription medicines to treat infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, multiple sclerosis, and colorectal cancer, as well as carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments.

Recommended Story: Understanding Stock Ratings

Leave a Reply

Your email address will not be published. Required fields are marked *